Novartis Leading Race to Acquire German Cancer Drug Maker MorphoSys

Novartis is reportedly leading the race to acquire German cancer drug maker MorphoSys, according to a recent report by Reuters. The news has caused a spike in MorphoSys’ share price, indicating significant market interest in the potential acquisition. Earlier this…